BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

949 related articles for article (PubMed ID: 26714229)

  • 1. Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition.
    Damerill I; Biggar KK; Abu Shehab M; Li SS; Jansson T; Gupta MB
    Mol Endocrinol; 2016 Feb; 30(2):201-16. PubMed ID: 26714229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.
    Abu Shehab M; Damerill I; Shen T; Rosario FJ; Nijland M; Nathanielsz PW; Kamat A; Jansson T; Gupta MB
    Endocrinology; 2014 Apr; 155(4):1327-39. PubMed ID: 24437487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGFBP-1 hyperphosphorylation in response to leucine deprivation is mediated by the AAR pathway.
    Malkani N; Jansson T; Gupta MB
    Mol Cell Endocrinol; 2015 Sep; 412():182-95. PubMed ID: 25957086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental Remote Control of Fetal Metabolism: Trophoblast mTOR Signaling Regulates Liver IGFBP-1 Phosphorylation and IGF-1 Bioavailability.
    Rosario FJ; Chopra A; Biggar K; Powell TL; Gupta MB; Jansson T
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Target of Rapamycin Complex 1 Signaling Links Hypoxia to Increased IGFBP-1 Phosphorylation in Primary Human Decidualized Endometrial Stromal Cells.
    Nandi P; Jang CE; Biggar K; Halari CD; Jansson T; Gupta MB
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms linking hypoxia to phosphorylation of insulin-like growth factor binding protein-1 in baboon fetuses with intrauterine growth restriction and in cell culture.
    Kakadia J; Biggar K; Jain B; Chen AW; Nygard K; Li C; Nathanielsz PW; Jansson T; Gupta MB
    FASEB J; 2021 Sep; 35(9):e21788. PubMed ID: 34425031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells.
    Misra UK; Pizzo SV
    PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
    Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
    J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
    Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
    J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperphosphorylation of fetal liver IGFBP-1 precedes slowing of fetal growth in nutrient-restricted baboons and may be a mechanism underlying IUGR.
    Kakadia JH; Jain BB; Biggar K; Sutherland A; Nygard K; Li C; Nathanielsz PW; Jansson T; Gupta MB
    Am J Physiol Endocrinol Metab; 2020 Sep; 319(3):E614-E628. PubMed ID: 32744097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Localization of Insulin-Like Growth Factor Binding Protein-1, Casein Kinase-2β, and Mechanistic Target of Rapamycin in Human Hepatocellular Carcinoma Cells as Demonstrated by Dual Immunofluorescence and in Situ Proximity Ligation Assay.
    Singal SS; Nygard K; Dhruv MR; Biggar K; Shehab MA; Li SS; Jansson T; Gupta MB
    Am J Pathol; 2018 Jan; 188(1):111-124. PubMed ID: 29037858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
    Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
    Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of decidual IGF-1 signaling in response to hypoxia and leucine deprivation is mediated by mTOR and AAR pathways and increased IGFBP-1 phosphorylation.
    Abu Shehab M; Biggar K; Kakadia JH; Dhruv M; Jain B; Nandi P; Nygard K; Jansson T; Gupta MB
    Mol Cell Endocrinol; 2020 Jul; 512():110865. PubMed ID: 32502935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells.
    Rosario FJ; Kanai Y; Powell TL; Jansson T
    J Physiol; 2013 Feb; 591(3):609-25. PubMed ID: 23165769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
    PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.
    Yin Y; Hua H; Li M; Liu S; Kong Q; Shao T; Wang J; Luo Y; Wang Q; Luo T; Jiang Y
    Cell Res; 2016 Jan; 26(1):46-65. PubMed ID: 26584640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
    Zhang X; Wang X; Xu T; Zhong S; Shen Z
    Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of rictor as a novel substrate of Polo-like kinase 1.
    Shao T; Liu X
    Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
    Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
    Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK-mTORC1 pathway mediates hepatic IGFBP-1 phosphorylation in glucose deprivation: a potential molecular mechanism of hypoglycemia-induced impaired fetal growth.
    Kakadia JH; Khalid MU; Heinemann IU; Han VK
    J Mol Endocrinol; 2024 Apr; 72(3):. PubMed ID: 38194365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.